炎症性肠病的复发因素研究进展
Research Progress of Relapse Factors in Inflammatory Bowel Disease
DOI: 10.12677/ACM.2022.127924, PDF,   
作者: 罗叶卿:大理大学临床医学院,云南 大理;杨永林*:大理大学第一附属医院消化内科,云南 大理
关键词: 炎症性肠病复发影响因素综述Inflammatory Bowel Disease (IBD) Recurrence Influencing Factors Review
摘要: 炎症性肠病(inflammatory bowel disease, IBD)主要包括溃疡性结肠炎(ulcerative colitis, UC)和克罗恩病(Crohn disease, CD),是一种主要累及胃肠道的非特异性、慢性、复发性、进展性的炎症性疾病。近年来在世界范围内,发病率逐渐上升,成为消化科的常见病。发病人群以青壮年为主,主要表现为持续性的腹泻、腹痛、呕吐、血便、粘液便等,具有病程长,容易复发等特点。虽然生物制剂治疗取得了较好的疗效,但复发率高、复发的确切因素仍难以肯定。近年来研究发现,IBD的复发与病程及病变范围、感染、饮食、生物标志、疾病治疗、生活方式、心理、基因等因素密切相关,现对于IBD的复发因素进行综述,应针对影响因素采取相应的措施,有利于预防IBD的复发,改善患者的预后提供帮助。
Abstract: Inflammatory bowel disease (IBD), whose main forms includes ulcerative colitis (UC) and Crohn’s disease (CD), is a non-specific, chronic, recurrent and progressive inflammatory disease that pri-marily affects the gastrointestinal tract. In recent years, IBD has gradually become a common dis-ease in gastroenterology, with its incidence rising worldwide. This disease is mainly affecting young adults and is characterized by persistent diarrhoea, abdominal pain, vomiting, bloody stools and mucous stools. Although biological agents have achieved good efficacy in the treatment of IBD, it is still hard to identify the causes for its high recurrence rate and specific factors for recurrence. Re-cently, it has been found that relapse of IBD is closely related to the duration and extent of the dis-ease, infection, diet, biomarkers, previous treatment methods, lifestyle, mental state, genes and other factors. A review of the relapse factors of IBD is presented in this paper, and appropriate measures should be taken to cope with the above influencing factors to prevent IBD recurrence and improve the prognosis of patients.
文章引用:罗叶卿, 杨永林. 炎症性肠病的复发因素研究进展[J]. 临床医学进展, 2022, 12(7): 6414-6420. https://doi.org/10.12677/ACM.2022.127924

参考文献

[1] 中国炎症性肠病营养诊疗共识[J]. 中华消化病与影像杂志(电子版), 2021, 11(1): 8-15.
[2] Ghouri, Y.A., Tahan, V. and Shen, B. (2020) Secondary Causes of Inflammatory Bowel Diseases. World Journal of Gastroenterology, 26, 3998-4017. [Google Scholar] [CrossRef] [PubMed]
[3] Sýkora, J., Pomahačová, R., Kreslová, M., et al. (2018) Current Global Trends in the Incidence of Pediatric-Onset Inflammatory Bowel Disease. World Journal of Gastroenter-ology, 24, 2714-2763. [Google Scholar] [CrossRef] [PubMed]
[4] 苏晓兰, 国嵩, 张涛, 等. 炎症性肠病诊治现状及中医药治疗特色与优势[J]. 北京中医药, 2020, 39(3): 211-215.
[5] 徐晓敏, 黄光明. 479例炎症性肠病患者复发相关危险因素临床分析[J]. 胃肠病学, 2015, 20(7): 411-416.
[6] Bhattacharya, S. and Cross, R.K. (2019) Is Endoscopic Remis-sion in Ulcerative Colitis Still Good Enough? Inflammatory Bowel Diseases, 25, 1729-1730. [Google Scholar] [CrossRef] [PubMed]
[7] 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年•北京) [J]. 中国实用内科杂志, 2018, 38(9): 796-813.
[8] 郑晓金, 兰辉宇, 郭瑞芳. 174例溃疡性结肠炎患者临床特征分析[J]. 中国实验诊断学, 2022, 26(1): 38-40.
[9] Nitzan, O., Elias, M., Peretz, A., et al. (2016) Role of Antibiotics for Treatment of Inflammatory Bowel Disease. World Journal of Gastroenterology, 22, 1078-1087. [Google Scholar] [CrossRef] [PubMed]
[10] Cai, R., Cheng, C., Chen, J., et al. (2020) Interactions of Commensal and Pathogenic Microorganisms with the Mucus Layer in the Colon. Gut Microbes, 11, 680-690. [Google Scholar] [CrossRef] [PubMed]
[11] 吴泽宇, 桑力轩, 姜敏, 等. 炎症性肠病肠道微生物紊乱研究进展[J]. 中国实用内科杂志, 2020, 40(1): 75-78.
[12] Mirsepasi-Lauridsen, H.C., Vallance, B.A., Krogfelt, K.A., et al. (2019) Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease. Clinical Microbiology Reviews, 32, e00060-18. [Google Scholar] [CrossRef
[13] 王莉, 黄海辉. 炎症性肠病合并艰难梭菌感染的研究进展[J]. 中国感染与化疗杂志, 2020, 20(6): 716-720.
[14] Zhang, X.F., Guan, X.X., Tang, Y.J., et al. (2021) Clinical Effects and Gut Microbiota Changes of Using Probiotics, Prebiotics or Synbiotics in Inflammatory Bowel Dis-ease: A Systematic Review and Meta-Analysis. European Journal of Nutrition, 60, 2855-2875. [Google Scholar] [CrossRef] [PubMed]
[15] Arslan, F. and Vahaboğlu, H. (2020) Cytomegalovirus and In-flammatory Bowel Disease, Reconsidering a “Result or Reason Dilemma” in Terms of Viral Pathogenesis and Medical Ethics. Expert Review of Gastroenterology & Hepatology, 14, 307-309. [Google Scholar] [CrossRef] [PubMed]
[16] 贾国葆, 吴建胜, 吴亮, 等. 巨细胞病毒在炎症性肠病中的临床意义及其诊治策略[J]. 医学研究杂志, 2017, 46(3): 102-105.
[17] 李婷, 王巧民. 炎症性肠病与病毒感染的关系[J]. 胃肠病学和肝病学杂志, 2018, 27(7): 813-816.
[18] 朱姗姗, 林梦月, 陈亚梅. 炎症性肠病患者饮食管理研究进展[J]. 现代消化及介入诊疗, 2021, 26(3): 409-413.
[19] Campmans-Kuijpers, M.J.E. and Dijkstra, G. (2021) Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients, 13, 1067. [Google Scholar] [CrossRef] [PubMed]
[20] Wark, G., Samocha-Bonet, D., Ghaly, S., et al. (2020) The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients, 13, 135. [Google Scholar] [CrossRef] [PubMed]
[21] Jiang, Y., Jarr, K., Layton, C., et al. (2021) Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases. Nutrients, 13, 890. [Google Scholar] [CrossRef] [PubMed]
[22] 邢瑞欣, 王洪乾, 章文慧, 等. 检测炎症性肠病患者血清铜/锌比值的临床意义[J]. 中华消化杂志, 2021, 41(10): 665-670.
[23] 陈菲, 马鸣. 营养素及特殊饮食治疗与炎症性肠病[J]. 中华临床营养杂志, 2021, 29(3): 171-179.
[24] Siva, S., Rubin, D.T., Gulotta, G., et al. (2017) Zinc Deficiency Is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 23, 152-157. [Google Scholar] [CrossRef
[25] Rokkas, T., Portincasa, P. and Koutroubakis, I.E. (2018) Fecal Calprotectin in Assessing Inflammatory Bowel Disease Endoscopic Activity: A Diagnostic Accuracy Me-ta-Analysis. The Journal of Gastrointestinal and Liver Diseases, 27, 299-306. [Google Scholar] [CrossRef] [PubMed]
[26] Campbell, J.P., Zierold, C., Rode, A.M., et al. (2021) Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Ir-ritable Bowel Syndrome. Journal of Clinical Gastroenterology, 55, 239-243. [Google Scholar] [CrossRef
[27] Khaki-Khatibi, F., et al. (2020) Calprotectin in Inflammato-ry Bowel Disease. Clinica Chimica Acta: International Journal of Clinical Chemistry, 510, 556-565. [Google Scholar] [CrossRef] [PubMed]
[28] 徐颜红, 刘婷, 姜云霞, 等. 炎症性肠病复发影响因素的范围综述[J]. 循证护理, 2021, 7(17): 2297-2306.
[29] 李秀美, 徐宁. 溃疡性结肠炎复发因素的研究现状[J]. 国际医药卫生导报, 2021, 27(21): 3429-3432.
[30] Seyedian, S.S., et al. (2019) A Review of the Diagnosis, Prevention, and Treatment Methods of Inflammatory Bowel Disease. Journal of Medicine and Life, 12, 113-122.
[31] Oligschlaeger, Y., Yadati, T., Houben, T., et al. (2019) Inflammatory Bowel Disease: A Stressed “Gut/Feeling”. Cells, 8, 659. [Google Scholar] [CrossRef] [PubMed]
[32] Le Berre, C., Loy, L., Lönnfors, S., et al. (2020) Patients’ Perspectives on Smoking and Inflammatory Bowel Disease: An Online Survey in Collaboration with European Federation of Crohn’s and Ulcerative Colitis Associations. World Journal of Gastroenterology, 26, 4343-4355. [Google Scholar] [CrossRef] [PubMed]
[33] 黄敏, 周刚, 骆宏. 炎症性肠病与精神心理因素关系的研究现状[J]. 健康研究, 2020, 40(5): 554-557+563.
[34] Jordi, S.B.U., Lang, B.M., Auschra, B., et al. (2022) Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 28, 560-571.
[35] 龚姗姗, 范一宏, 吕锟, 等. 炎症性肠病心理因素研究进展[J]. 中华消化杂志, 2018, 38(9): 643-645.
[36] Rozich, J.J., et al. (2020) Effect of Lifestyle Factors on Outcomes in Patients with Inflammatory Bowel Diseases. The American Journal of Gastroenterology, 115, 832-840. [Google Scholar] [CrossRef] [PubMed]
[37] Mikocka-Walus, A., Pittet, V., Rossel, J.B., et al. (2016) Symptoms of Depression and Anxiety Are Independently Associated with Clin-ical Recurrence of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 14, 829-835.e1.
[38] Ternant, D., Berkane, Z., Picon, L., et al. (2015) Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease. Clinical Pharmacokinetics, 54, 551-562. [Google Scholar] [CrossRef] [PubMed]
[39] Kakuta, Y., Kimura, T., Negoro, K., et al. (2017) Increased Expression of IL12b mRNA Transcribed from the Risk Haplotype for Crohn’s Disease Is a Risk Factor for Disease Relapse in Japanese Patients. Journal of Gastroenterology, 52, 1230-1239. [Google Scholar] [CrossRef] [PubMed]
[40] Gordon, H., Blad, W., Trier Møller, F., et al. (2021) UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD. Digestive Diseases and Sciences, 67, 2444-2450. [Google Scholar] [CrossRef] [PubMed]
[41] Larabi, A., Barnich, N. and Nguyen, H. (2020) New Insights into the Interplay between Autophagy, Gut Microbiota and Inflammatory Responses in IBD. Autophagy, 16, 38-51. [Google Scholar] [CrossRef] [PubMed]
[42] 宋杨达, 钟英强. 自噬异常与炎症性肠病发病的关系[J]. 胃肠病学, 2017, 22(5): 304-307.